摘要
仝小林院士认为,肝癌发生因正虚邪实,核心病机为虚损生积,毒瘀内结,治疗上宜通络、扶正、祛邪,结合临床靶药治疗经验,提出淫羊藿、莪术、三七为治疗肝癌的靶药,其中淫羊藿温补脾肾,扶正以攻无形之癌毒,莪术消积止痛,消有形之癌块,三七活血止血,通络以抗纤维化。用于治疗肝癌,淫羊藿入汤剂用量15~30 g,最大可用至60 g;莪术用量15~45 g,最大可用至120 g;三七粉剂冲服用3~6 g,饮片入煎剂用9~30 g。
With the increasing incidence of cancers,safe and effective treatment methods are worthy of attention and promotion.Among them,Chinese medicine anti-cancer treatment has attracted more and more attention in recent years.Academician Tong Xiaolin believes that the occurrence of liver cancer is due to vital qi deficiency and pathogen excess,and the core pathogenesis is pathogen stagnation owing to vital qi deficiency and the internal binding of toxin and blood stasis.In its treatment,it is advisable to dredge collaterals,strengthen the body and eliminate pathogens.Combined with the clinical experience of target drug therapy,he proposes that epimedium herb,zedoray rhizome and sanqi be used as the target drugs for the treatment of liver cancer.Among them,epimedium herb warms spleen and kidney,strengthening the body to attack invisible cancer toxins.Zedoray rhizome resolves stagnation and relieves pain,eliminating visible cancer blocks.Sanqi promotes blood circulation to stop bleeding,clearing collaterals to prevent fibrosis.For the treatment of liver cancer,the dosage of epimedium herb in decoction is mostly 15-30 g,with 60 g as the maximum;Zedoray rhizome in decoction is mostly 15-45 g,with 120 g as the maximum;The dosage of sanqi powder,when taken orally,is 3-6 g,and when used as processed drug in decoction,9-30 g.
作者
杜林
陈德瑶
顾成娟
李培
DU Lin;CHEN Deyao;GU Chengjuan;LI Pei(Shenzhen Hospital of Guangzhou University of Chinese Medicine<Futian>,Shenzhen 518000,China)
出处
《吉林中医药》
2021年第1期16-18,共3页
Jilin Journal of Chinese Medicine
基金
国家自然科学基金重点项目(81430097)。
关键词
肝癌
淫羊藿
莪术
三七
仝小林
liver cancer
epimedium herb
zedoray rhizome
sanqi
Tong Xiaolin
